Literature DB >> 7829781

Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction.

S J Brener1, C I Duffy, J D Thomas, W J Stewart.   

Abstract

OBJECTIVES: This study reports the results of echocardiographic follow-up in a large cohort of patients with aortic stenosis and correlates the progression of aortic stenosis with changes in the degree of mitral regurgitation and left ventricular hypertrophy and systolic dysfunction.
BACKGROUND: Progressive aortic stenosis often causes left ventricular dysfunction and mitral regurgitation. Doppler echocardiography has greatly assisted in the noninvasive evaluation and follow-up of aortic stenosis. Nevertheless, the longitudinal follow-up of patients with Doppler echocardiography for the progression of aortic stenosis and the significance of progressive ventricular hypertrophy and mitral regurgitation have not been reported.
METHODS: Serial Doppler echocardiography was performed in 394 consecutive patients with valvular aortic stenosis at baseline and after a mean follow-up period of 37 +/- 16 months. Mean and peak aortic gradients, aortic valve area, left ventricular systolic and diastolic diameters and percent area change (shortening fraction) were expressed as continuous variables, and systolic dysfunction, mitral regurgitation, ventricular hypertrophy and filling properties were tabulated as categoric variables using a semiquantitative grading system.
RESULTS: Peak and mean gradients increased by an average of 8.3 and 6.3 mm Hg/year, respectively; end-systolic and end-diastolic diameters increased by 1.9 and 1.6 mm/year, respectively; and aortic valve area decreased by 0.14 cm2/year during the follow-up interval (p < 0.001 for all), indicating progression of aortic stenosis and ventricular dilation. Patients in the lowest quartile of aortic valve area and highest quartiles of mean and peak gradients had the least change compared with those in the highest quartile of aortic valve area and lowest quartile of mean and peak gradients (p < 0.01 for all). Patients with more mitral regurgitation at follow-up than at baseline had higher mean percent increase in mean and peak gradients as well as more progression of ventricular dilation and worsening systolic function compared with those with stable or improving mitral regurgitation (p < 0.05 for all). Similarly, subjects with worsening left ventricular hypertrophy had larger mean percent increase in mean and peak gradients than those with stable left ventricular hypertrophy (p < 0.01) but maintained stable ventricular volumes and systolic function. There was no correlation between the amount of change in mean or peak gradients and degree of deterioration in systolic function.
CONCLUSIONS: Aortic stenosis progresses predictably over time; however, systolic dysfunction is an inconsistent marker of the hemodynamic consequences of severe aortic stenosis. As an adaptive response to pressure overload, progressive hypertrophy appears to prevent ventricular dilation and development or worsening of mitral regurgitation. Conversely, progressive mitral regurgitation may be seen as a maladaptive consequence of increasing aortic stenosis.

Entities:  

Mesh:

Year:  1995        PMID: 7829781     DOI: 10.1016/0735-1097(94)00406-g

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  21 in total

Review 1.  Interface between valve disease and ischaemic heart disease.

Authors:  B Iung
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

2.  Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.

Authors:  Ashvin R Kamath; Ramdas G Pai
Journal:  Int J Angiol       Date:  2008

Review 3.  Transcatheter aortic valve replacement in patients with severe aortic stenosis and heart failure.

Authors:  Chirag Bavishi; Dhaval Kolte; Paul C Gordon; J Dawn Abbott
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

4.  Factors determining early improvement in mitral regurgitation after aortic valve replacement for aortic valve stenosis: a transthoracic and transesophageal prospective study.

Authors:  Sophe Tassan-Mangina; Damien Metz; Pierre Nazeyllas; Frederic Torossian; Cameia Pop; Jamet Bertrand; Bernard Baehrel; Jacques Elaerts
Journal:  Clin Cardiol       Date:  2003-03       Impact factor: 2.882

5.  Long axis excursion in aortic stenosis.

Authors:  S Takeda; H Rimington; N Smeeton; J Chambers
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

6.  Progression rate of severity of aortic stenosis in patients with rheumatoid arthritis.

Authors:  John P Bois; Cynthia S Crowson; Tamanna Khullar; Sara J Achenbach; Megan L Krause; Rekha Mankad
Journal:  Echocardiography       Date:  2017-08-25       Impact factor: 1.724

7.  Dynamics of Concomitant Functional Mitral Regurgitation in Patients with Aortic Stenosis Undergoing TAVI.

Authors:  Asife Sahinarslan; Francesco Vecchio; Philip MacCarthy; Rafal Dworakowski; Ranjit Deshpande; Olaf Wendler; Mark Monaghan
Journal:  Acta Cardiol Sin       Date:  2016-07       Impact factor: 2.672

Review 8.  Changing strategy for aortic stenosis with coronary artery disease by transcatheter aortic valve implantation.

Authors:  Junjiro Kobayashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-04-02

9.  Should a regurgitant mitral valve be replaced simulataneously with a stenotic aortic valve?

Authors:  J T Christenson; B Jordan; A Bloch; M Schmuziger
Journal:  Tex Heart Inst J       Date:  2000

10.  Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure.

Authors:  Sushma Reddy; Mingming Zhao; Dong-Qing Hu; Giovanni Fajardo; Shijun Hu; Zhumur Ghosh; Viswanathan Rajagopalan; Joseph C Wu; Daniel Bernstein
Journal:  Physiol Genomics       Date:  2012-03-27       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.